Transgene SA
Patents, Design & Utilities
Last updated:
List of all Transgene SA patents 10 in total
| Status | Patent |
|---|---|
Application | Utility: M2-DEFECTIVE POXVIRUS Filling date: 9 Sep 2025 Issue date: 24 Feb 2022 |
Application | Utility: NOVEL ANTIBODIES AND NUCLEOTIDE SEQUENCES, AND USES THEREOF Filling date: 9 Sep 2025 Issue date: 10 Feb 2022 |
Application | Utility: COMBINATION OF ONCOLYTIC VIRUS WITH IMMUNE CHECKPOINT MODULATORS Filling date: 9 Sep 2025 Issue date: 3 Dec 2020 |
Grant | Utility: Combination of oncolytic virus with immune checkpoint modulators Filling date: 9 Sep 2025 Issue date: 8 Sep 2020 |
Grant | Utility: Fusion of heterooligomeric mycobacterial antigens Filling date: 9 Sep 2025 Issue date: 8 Sep 2020 |
Application | Utility: ONCOLYTIC VIRUS FOR EXPRESSION OF IMMUNE CHECKPOINT MODULATORS Filling date: 9 Sep 2025 Issue date: 25 Jun 2020 |
Grant | Utility: Oncolytic virus for expression of immune checkpoint modulators Filling date: 9 Sep 2025 Issue date: 11 Feb 2020 |
Grant | Utility: Stable liquid vaccinia virus formulations Filling date: 9 Sep 2025 Issue date: 31 Dec 2019 |
Application | Utility: ONCOLYTIC VIRUSES AND THERAPEUTIC MOLECULES Filling date: 9 Sep 2025 Issue date: 31 Oct 2019 |
Application | Utility: IMMUNOTHERAPEUTIC PRODUCT AND MDSC MODULATOR COMBINATION THERAPY Filling date: 9 Sep 2025 Issue date: 31 Oct 2019 |
Showing 1 to 10 of 10 patents.